https://www.selleckchem.com/pr....oducts/solcitinib.ht
003). PCZ initiation, regardless of galenic form, increased TAC and EVR Cmin adjusted for dose (D), 3-fold and 3.5-fold, respectively (P less then .0001 for both). PCZ-tab treatment was associated with a higher TAC Cmin /D (PCZ-tab vs PCZ-susp 0.004 ± 0.004 L-1 vs 0.009 ± 0.006 L-1 , P less then .0001) and lower TAC daily dose than PCZ-susp (PCZ-tab vs PCZ-susp 1.08 ± 0.92 vs 2.32 ± 1.62 mg d-1 , P less then .0001). EVR Cmin /D was higher and EVR dose tended to be lower on PCZ-tab than on PCZ-susp. Conclusion The greater PCZ exposure
Like
Comment
Share
